{
    "clinical_study": {
        "@rank": "92361", 
        "arm_group": [
            {
                "arm_group_label": "dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "addition of dexmedetomidine to fentanyl-based intravenous patient controlled analgesia (PCA)"
            }, 
            {
                "arm_group_label": "normal saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "normal saline as a placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to test the hypothesis that addition of dexmedetomidine to\n      fentanyl-based intravenous patient controlled analgesia (PCA) reduces requirement of\n      fentanyl bolus and consequent postoperative nausea and vomiting in high-risk patients\n      undergoing lumbar spine surgery."
        }, 
        "brief_title": "Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "PONV", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1. female, non-smoking patient who are 20-65 of age scheduled for elective lumbar spine\n        surgery\n\n        Exclusion Criteria:\n\n          1. Bradycardia on EKG (45bpm)\n\n          2. Atrioventricular conduction disorder\n\n          3. Uncontrolled hypertension\n\n          4. angina history\n\n          5. obesity (BMI \u2265 30 kg/m2)\n\n          6. Preoperative administration of opioid\n\n          7. Preoperative administration of antiemetics\n\n          8. Gastrointestinal disorder history\n\n          9. Hepatic or renal disease\n\n         10. Pregnant 11. Foreigner"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01840254", 
            "org_study_id": "4-2012-0490"
        }, 
        "intervention": [
            {
                "arm_group_label": "dexmedetomidine", 
                "intervention_name": "dexmedetomidine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "normal saline", 
                "intervention_name": "normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Dexmedetomidine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PONV", 
            "IV PCA", 
            "dexmedetomidine", 
            "Female", 
            "non-smoking", 
            "lumbar spine surgery"
        ], 
        "lastchanged_date": "February 5, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Yonsei University College of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "After induction of anesthesia, peak velocity of carotid artery blood flow is measured by the pulsed wave Doppler signal obtained from the left common carotid artery. Respirophasic variation of the peak velocity is defined as the  difference between the maximum and the minimum values of peak velocity divided by the mean of the two values during one respiratory cycle.  Fluid responder is defined as a patient whose stroke volume index is increased  \u226515% after volume expansion. The receiver operating characteristic curve analysis to discriminiate fludi responder is performed.", 
            "measure": "total dose and bolus administration of opioid", 
            "safety_issue": "No", 
            "time_frame": "an expected average of 48 hrs for  requirements of total dose and number of bolus administration of PCA"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01840254"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "After induction of anesthesia, peak velocity of carotid artery blood flow is measured by the pulsed wave Doppler signal obtained from the left common carotid artery. Respirophasic variation of the peak velocity is defined as the difference between the maximum and the minimum values of peak velocity divided by the mean of the two values during one respiratory cycle. Fluid responder is defined as a patient whose stroke volume index is increased \u226515% after volume expansion. The receiver operating characteristic curve analysis to discriminate fluid responder is performed.", 
            "measure": "consequent postoperative nausea and vomiting", 
            "safety_issue": "No", 
            "time_frame": "an expected average of 48 hrs for assessing of the 11-points verbal numerical rating scales"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}